Nicholas Piramal India has entered into a long-term strategic alliance with US-based DxTech, a subsidiary of XL TechGroup.

Nicholas Piramal India (NPIL), one of the largest pharmaceutical and healthcare companies in India has entered into a long-term strategic alliance with US-based DxTech, a subsidiary of XL TechGroup. The strategic alliance includes a product development and licensing agreement, a distribution agreement and the establishment of a joint venture sales and marketing company in India. The deal gives Nicholas Piramal an exclusive license to DxTech's Vantix platform in India, Pakistan, Bangladesh, Sri Lanka, Nepal and Bhutan.